Cleroux J, Leenen F H
Hypertension Unit, Toronto Western Hospital, Ontario, Canada.
Am J Hypertens. 1988 Jul;1(3 Pt 3):290S-294S. doi: 10.1093/ajh/1.3.290s.
Endurance during prolonged exercise decreases more markedly with nonselective than beta 1-selective beta-blockade. Because both types of blockers exert comparable effects on cardiac performance, oxygen supply to the working muscle, and extramuscular substrate mobilization, the difference in exercise capacity is apparently due to other factors. The available information in the literature along with experimental results from our laboratory suggests that inhibition of intramuscular lipolysis only occurs with nonselective beta-blockade and may partly account for this difference. In addition, alterations in potassium fluxes are particularly induced by nonselective beta-blockade and result in more pronounced decreases in the intracellular-extracellular potassium ratio during exercise than caused by placebo or beta 1-selective blockade. In contrast to what was initially proposed, intramuscular glycogenolysis appears not to be affected by either type of beta-blockade, and a decrease is unlikely to be involved in the reduced exercise capacity.
与β1选择性β受体阻滞剂相比,非选择性β受体阻滞剂使长时间运动中的耐力下降更为明显。由于这两种类型的阻滞剂对心脏功能、工作肌肉的氧气供应和肌肉外底物动员的作用相当,运动能力的差异显然是由其他因素导致的。文献中的现有信息以及我们实验室的实验结果表明,只有非选择性β受体阻滞剂会抑制肌肉内脂肪分解,这可能是造成这种差异的部分原因。此外,非选择性β受体阻滞剂特别会引起钾离子通量的改变,导致运动期间细胞内外钾离子比率的下降比安慰剂或β1选择性阻滞剂引起的更为明显。与最初的推测相反,肌肉内糖原分解似乎不受任何一种β受体阻滞剂的影响,运动能力下降也不太可能与之有关。